Search Results - timothy+murphy

3 Results Sort By:
Novel Fusion Protein Vaccine for Moraxella Catarrhalis Infections
A fusion protein vaccine designed to prevent COPD exacerbations and pediatric acute otitis media. Background: Respiratory infections caused by Moraxella catarrhalis (Mcat) represent a growing public health concern. In children, Mcat is a leading cause of otitis media, a common middle ear infection affecting most children by age three, frequently...
Published: 4/16/2026   |   Updated: 3/23/2026   |   Inventor(s): Timothy Murphy, Patricia Weber
Keywords(s): Featured, Technologies
Category(s): Campus > University at Buffalo, Technology Classifications > Therapeutics and Vaccines, Technology Classifications > Antibodies
Vaccine to Prevent Otitis Media and Infections in COPD
Moraxella catarrhalis antigen AfeA immunization of chronic obstructive pulmonary disease (COPD) patients. Chronic obstructive pulmonary disease (COPD) is a progressive and irreversible lung disease characterized by chronic inflammation reduced air flow. It is associated with smoke inhalation (typically from cigarettes or cooking fires) and air pollution...
Published: 4/16/2026   |   Updated: 1/9/2018   |   Inventor(s): Timothy Murphy, Aimee Brauer
Keywords(s): Technologies
Category(s): Technology Classifications > Therapeutics and Vaccines, Campus > University at Buffalo
Novel Vaccine Antigens for Moraxella Catarrhalis
Several vaccine targets developed to Moraxella catarrhalis, a pathogen found in otitis media (middle ear infection) and chronic pulmonary obstruction disease (COPD). Otitis media (OM), or middle ear infection, is one of the most common reasons for pediatric office visits. An estimated 30 million office visits can be attributed to OM every year. Eighty...
Published: 4/16/2026   |   Updated: 5/22/2014   |   Inventor(s): Timothy Murphy, Charmaine Kirkham, Alan J Lesse
Keywords(s): Technologies
Category(s): Technology Classifications > Therapeutics and Vaccines, Campus > University at Buffalo